Overview
Adam Giess practices practicing medicine in London, United Kingdom.
His clinical expertise encompasses Myxoid Liposarcoma, Spinal Muscular Atrophy Type 3, and Spinal Muscular Atrophy Type 2.
He is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Adam P. Giess
Is Adam P. Giess a top-rated expert for Myxoid Liposarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Adam P. Giess is classified as an Experienced expert for Myxoid Liposarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Adam P. Giess participate in research or clinical trials?
Yes. Adam P. Giess has published 20 articles and abstracts on conditions like Myxoid Liposarcoma. You can view a list of Adam P. Giess's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Myxoid LiposarcomaMr. Giess isExperienced. Learn about Myxoid Liposarcoma.
- Spinal Muscular Atrophy Type 2Mr. Giess isExperienced. Learn about Spinal Muscular Atrophy Type 2.
- Spinal Muscular Atrophy Type 3Mr. Giess isExperienced. Learn about Spinal Muscular Atrophy Type 3.